Venture
Moonfire Ventures raises USD 115m to back early-stage startups in Europe
AI-powered VC firm has raised USD 90m for Fund II and USD 25m for its Opportunity Fund to double down on winners
Hamilton Lane targets global impact opportunities with new USD 370m fund
Asset manager’s new fund will make direct investments and can take larger stakes than its USD 95m predecessor
Bregal Milestone closes second tech fund on EUR 770m
European technology investor has around 60% dry powder remaining to deploy in its latest fund
Polestar Capital to raise up to EUR 500m for new e-mobility investment strategy
Dutch GP plans to close new vehicle in mid-2024 as Circular Debt fundraising continues
OTB Ventures heads for EUR 150m-plus final close of second fund next month
Deeptech-focused VC expects to make two to three more deals this year, Adam Niewinski said
VFF has around EUR 20m to deploy, considers fund volume and investment period increase
Slovak state-backed VC fund expects to invest in 25-30 companies with EUR 500,000 to EUR 4.8m to deploy per round
Heran Partners nears full deployment of debut fund, mulls next fundraise
Health tech-focused VC is seeking three further software and hardware deals from EUR 75m debut vehicle
HV Capital doubles down on DACH investments with new EUR 710m early-stage and growth fund
Fund IX is the German VC and growth firm’s largest fundraise to date and will be split into two separate vehicles for venture and growth
Newly launched Utopia Capital aims to deploy EUR 10m-plus by 2028
Angel investor Christian Schroeder's new investment vehicle will support early-stage tech companies addressing humanitarian issues
VC Profile: HTGF optimistic on seed stage opportunities as exit environment toughens
German seed investor secured almost EUR 500m for its fourth and biggest fund to date at a time when VC funding is slowing down
4Impact heads for year-end close for EUR 125m second fund
Founded by ex-Goldman Sachs team, impact VC firm has made one investment from its latest fund so far
Forbion raises combined EUR 1.35bn for venture and growth funds
Ventures Fund VI closes on EUR 750m and Growth Opportunities II on EUR 600m with both upsized by over 60%
Gilde Healthcare hits EUR 600m target for Venture&Growth VI
Fund is 50% larger than predecessor thanks to “loyal” LP base; seeks late-stage deployment in medtech, digital health and therapeutics
VC fundraising sinks further with lowest Q1 in a decade
Eight European firms secured just over EUR 2bn in commitments in Q1 2023 as continuing uncertainty suppresses LPs’ risk appetite, but fundraising pipeline looks promising
VC Profile: Hi Inov in pre-marketing for next fund, outlines plans to wrap up Fund II investment period
France and Germany-based early-stage investor has made 15 of its up to 20 planned investments from its EUR 100m Fund II
Infravia aims to raise up to EUR 1bn for next growth fund, eyes mid-2024 launch
French sponsor expects to raise EUR 750m-EUR 1bn for B2B tech-focused second growth fund
VC Profile: Target Global assesses B2B opportunities in final stretch of current fund deployment
Nearing full deployment for its second growth fund, pan-European VC firm outlines plans to back defensive B2B models and institutionalise its co-investment strategy and LP base
EQT closes LSP Dementia on EUR 260m hard cap
Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy
Newton Biocapital heads for year-end close for second, EUR 150m life sciences fund
Belgian-Japanese VC has raised EUR 50m to date and is lining up exits from its debut fund
Sofinnova launches digital medicine strategy
Life sciences sponsor’s sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Nation 1 launches new early-stage, EUR 35m-EUR 40m fund
Czech investor targets first close in 1Q24, seeking to attract institutional investors and at least one bank
Beyond Impact aims for EUR 100m close for alternative protein fund
Article 9 fund held EUR 25m first close in early 2022; targets stakes in non-animal proteins and ingredients
Women in VC: Turenne Santé’s Chaoui on new healthcare growth strategy and social impact
Healthcare sponsor aims to raise EUR 150m for new growth fund, with further deployment and fundraising for its LBO strategy in the pipeline
Nekko aims to reach EUR 10m hard-cap for N Venture I within six months
Spanish VC firm plans to build on the vehicle’s EUR 6m first close, with nine companies backed so far